Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), Country (Germany, U.K. France, Italy, Spain, Switzerland, Netherlands, Russia, Belgium, Turkey, Rest of Europe) Market Trends and Forecast to 2027
Some of the major factors contributing to the growth of the market are:
• Rising R&D activity
• Increasing usage of X-ray for chronic diseases
Market Players:
The key market players for Europe for iodinated contrast media in interventional X-ray market are listed below:
• Bayer AG
• Iso-Tex Diagnostics, Inc.
• Bracco Diagnostic Inc.
• Novalek Pharmaceuticals Pvt. Ltd.
• iMAX
• Taejoon Pharm
• Unijules Life Sciences Ltd
• General Electric
• Guerbet LLC
• J.B.Chemicals & Pharmaceuticals Ltd
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 APPLICATION GRID
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTION
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS
3.1.2 RISING AGING POPULATION
3.1.3 INCREASING NUMBER OF CHRONIC DISEASES
3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS
3.2 RESTRAINTS
3.2.1 HIGH COST OF CONTRAST MEDIA
3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
3.3 OPPORTUNITIES
3.3.1 GROWING HEALTHCARE INFRASTRUCTURE
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS
3.4 CHALLENGES
3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT
3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION
6.1 OVERVIEW
6.2 INTRAVENOUS
6.3 ORAL
6.4 RECTAL
6.5 OTHERS
7 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL
7.3 SPECIALTY CLINICS
7.3.1 IMAGING CENTERS
7.3.2 PRIVATE PRACTICES
7.4 DIAGNOSTIC CENTERS
7.5 AMBULATORY SURGICAL CENTERS
7.6 RESEARCH & ACADEMIC INSTITUTES
8 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION
8.1 OVERVIEW
8.2 CARDIOLOGY
8.2.1 PERCUTANEOUS CORONARY DISEASE
8.2.2 STRUCTURAL HEART DISEASE
8.2.3 CONGENITAL HEART DISEASE
8.2.4 ELECTROPHYSIOLOGY
8.3 NEUROLOGY
8.4 GENERAL SURGERY
8.5 ONCOLOGY
8.6 UROLOGY
9 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE
9.1 OVERVIEW
9.2 NON-IONIC
9.3 IONIC
10 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 U.K.
10.1.3 FRANCE
10.1.4 ITALY
10.1.5 SPAIN
10.1.6 SWITZERLAND
10.1.7 NETHERLANDS
10.1.8 RUSSIA
10.1.9 BELGIUM
10.1.10 TURKEY
10.1.11 REST OF EUROPE
11 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 COMPANY PROFILES
12.1 BRACCO DIAGNOSTIC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 COMPANY SHARE ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 RECENT DEVELOPMENT
12.2 GENERAL ELECTRIC
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 GUERBET
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 BAYER AG
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENT
12.5 IMAX
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENT
12.6 ISO-TEX DIAGNOSTICS, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 NOVALEK PHARMACEUTICALS PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 TAEJOON PHARM
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.10 UNIJULES LIFE SCIENCES LTD.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
UU
TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS
TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS
TABLE 3 COST OF CONTRAST MEDIA
TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS
TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT
TABLE 6 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 7 EUROPE INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 EUROPE ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 9 EUROPE RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 10 EUROPE OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 12 EUROPE HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 14 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 15 EUROPE DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 16 EUROPE AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 EUROPE RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 19 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 21 EUROPE NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 EUROPE GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 EUROPE ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 EUROPE UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 26 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)
TABLE 27 EUROPE NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 EUROPE IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 30 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 31 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 32 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 33 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 34 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 35 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 36 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 37 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 38 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 39 GERMANY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 40 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 41 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 42 GERMANY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 43 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 44 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 45 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 46 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 47 U.K. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 48 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 49 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 50 U.K. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 51 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 52 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 53 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 54 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 55 FRANCE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 56 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 57 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 58 FRANCE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 59 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 60 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 61 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 62 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 63 ITALY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 64 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 65 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 66 ITALY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 67 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 68 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 69 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 70 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 71 SPAIN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 72 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 73 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 74 SPAIN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 75 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 76 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 77 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 78 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 79 SWITZERLAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 80 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 81 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 82 SWITZERLAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 83 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 84 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 85 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 86 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 87 NETHERLANDS CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 88 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 89 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 90 NETHERLANDS SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 91 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 92 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 93 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 94 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 95 RUSSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 96 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 97 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 98 RUSSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 99 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 100 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 101 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 102 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 103 BELGIUM CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 104 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 105 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 106 BELGIUM SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 107 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 108 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 109 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 110 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 111 TURKEY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 112 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 113 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 114 TURKEY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 115 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 116 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 117 REST OF EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...